Delivery Order SPE2DB22D3016-SPE2DB24FAFE4
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,352.40 for the pharmaceutical product ENBREL 50 MG/ML SURECLICK. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 27, 2021, with an ultimate completion date of October 28, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $20,914.83 for the supply of ENBREL 50 MG/ML SURECLICKML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2021. The contract is a Firm Fixed Price agreement and is not designated as a set-aside requirement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,158.98 for the supply of ENBREL 50 MG/ML SURECLICK. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of ENBREL 50 MG/ML SURECLICK pharmaceutical products. The firm-fixed-price delivery order, valued at $19,266.88, has a completion date of January 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award for $28,513.38 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, a Delivery Order under an Indefinite Delivery Contract (IDC), is for the provision of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The IDC, valued at up to $999,999,999.00, is the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,200.41 firm fixed-price delivery order contract is for the supply of Enbrel 50 mg/mL SureClick medication. The contract has an ultimate completion date of January 29, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $11,440.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $23,180.97, is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of Enbrel 50 mg/mL SureClick medication to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $81,166.80 and runs through September 15, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary...
- This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product Enbrel 50 mg/mL SureClick. The award, valued at $3,579.49, is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAFE4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $20,393.93, is for the delivery of the medication Enbrel 50 mg/mL SureClick and has a completion date of December 8, 2023. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business category. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00 respectively. These IDCs enable the company to efficiently provide a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs, including those serving the Department of Defense and military treatment facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 12/7/23 |